Germany · Delayed Price · Currency is EUR SynBiotic SE Statistics
Total Valuation
SynBiotic SE has a market cap or net worth of EUR 8.61 million. The enterprise value is 8.70 million.
| Market Cap | 8.61M |
| Enterprise Value | 8.70M |
Important Dates
The next estimated earnings date is Monday, August 17, 2026.
| Earnings Date | Aug 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 6.82M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | n/a |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.58 |
| PB Ratio | 0.41 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.44, with a Debt / Equity ratio of 0.13.
| Current Ratio | 0.44 |
| Quick Ratio | 0.11 |
| Debt / Equity | 0.13 |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.03 |
| Interest Coverage | -7.63 |
Financial Efficiency
Return on equity (ROE) is -59.95% and return on invested capital (ROIC) is -9.59%.
| Return on Equity (ROE) | -59.95% |
| Return on Assets (ROA) | -5.07% |
| Return on Invested Capital (ROIC) | -9.59% |
| Return on Capital Employed (ROCE) | -10.81% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 188,077 |
| Profits Per Employee | -122,990 |
| Employee Count | 55 |
| Asset Turnover | 0.37 |
| Inventory Turnover | 3.32 |
Taxes
In the past 12 months, SynBiotic SE has paid 14,152 in taxes.
| Income Tax | 14,152 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.02% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -68.02% |
| 50-Day Moving Average | 4.37 |
| 200-Day Moving Average | 6.50 |
| Relative Strength Index (RSI) | 33.06 |
| Average Volume (20 Days) | 330 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SynBiotic SE had revenue of EUR 14.86 million and -9.72 million in losses. Loss per share was -1.66.
| Revenue | 14.86M |
| Gross Profit | 5.41M |
| Operating Income | -3.27M |
| Pretax Income | -10.88M |
| Net Income | -9.72M |
| EBITDA | -2.51M |
| EBIT | -3.27M |
| Loss Per Share | -1.66 |
Balance Sheet
The company has 690,174 in cash and 2.64 million in debt, with a net cash position of -1.95 million.
| Cash & Cash Equivalents | 690,174 |
| Total Debt | 2.64M |
| Net Cash | -1.95M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 21.01M |
| Book Value Per Share | 3.35 |
| Working Capital | -8.58M |
Cash Flow
In the last 12 months, operating cash flow was -503,126 and capital expenditures -151,399, giving a free cash flow of -654,525.
| Operating Cash Flow | -503,126 |
| Capital Expenditures | -151,399 |
| Depreciation & Amortization | 8.42M |
| Net Borrowing | -351,665 |
| Free Cash Flow | -654,525 |
| FCF Per Share | n/a |
Margins
Gross margin is 36.44%, with operating and profit margins of -22.02% and -65.39%.
| Gross Margin | 36.44% |
| Operating Margin | -22.02% |
| Pretax Margin | -73.20% |
| Profit Margin | -65.39% |
| EBITDA Margin | -16.91% |
| EBIT Margin | -22.02% |
| FCF Margin | n/a |
Dividends & Yields
SynBiotic SE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -274.81% |
| Shareholder Yield | -274.81% |
| Earnings Yield | -112.82% |
| FCF Yield | -7.60% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for SynBiotic SE is 6.05, which is 427.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 6.05 |
| Price Target Difference | 427.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 70.24% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SynBiotic SE has an Altman Z-Score of -1.09 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1.09 |
| Piotroski F-Score | 2 |